News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
COMMODORE CAPITAL LP
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/06/2023 |
SC 13G/A
| COMMODORE CAPITAL LP reports a 9.9% stake in Vistagen Therapeutics, Inc. |
| 04/27/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/28/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2023 |
SC 13G/A
| COMMODORE CAPITAL LP reports a 9.5% stake in Imara Inc. |
| 02/14/2023 |
SC 13G/A
| COMMODORE CAPITAL LP reports a 1.7% stake in Karyopharm Therapeutics, Inc. |
| 02/14/2023 |
SC 13G/A
| COMMODORE CAPITAL LP reports a 0% stake in VistaGen Therapeutics, Inc. |
| 02/14/2023 |
SC 13G/A
| COMMODORE CAPITAL LP reports a 4.2% stake in BELLUS Health Inc. |
| 02/14/2023 |
SC 13G/A
| COMMODORE CAPITAL LP reports a 6.8% stake in CymaBay Therapeutics, Inc. |
| 02/14/2023 |
SC 13G/A
| COMMODORE CAPITAL LP reports a 6.3% stake in Immunic, Inc. |
| 02/14/2023 |
SC 13G/A
| COMMODORE CAPITAL LP reports a 9.9% stake in Celcuity Inc. |
| 02/14/2023 |
SC 13G/A
| COMMODORE CAPITAL LP reports a 5.9% stake in Merus N.V. |
| 02/14/2023 |
SC 13G/A
| COMMODORE CAPITAL LP reports a 7% stake in Cogent Biosciences, Inc. |
| 11/16/2022 |
SC 13G/A
| COMMODORE CAPITAL LP reports a 0% stake in Satsuma Pharmaceuticals, Inc. |
| 02/14/2022 |
SC 13G/A
| COMMODORE CAPITAL LP reports a 11.8% stake in Satsuma Pharmaceuticals, Inc. |
| 02/14/2022 |
SC 13G/A
| COMMODORE CAPITAL LP reports a 5.4% stake in Genocea Biosciences, Inc. |
| 02/14/2022 |
SC 13G/A
| COMMODORE CAPITAL LP reports a 7.8% stake in CymaBay Therapeutics, Inc. |
| 02/14/2022 |
SC 13G/A
| COMMODORE CAPITAL LP reports a 5.7% stake in Cogent Biosciences, Inc. |
| 02/14/2022 |
SC 13G/A
| COMMODORE CAPITAL LP reports a 6.2% stake in Celcuity Inc. |
| 10/19/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
|
|